Here are five observations:
1. The neurostimulation devices segment is leading the market, due to the increasing supportive clinical data of the devices’ safety and effectiveness.
2. Growing popularity of minimally invasive surgeries and increasing availability of neurosurgical devices will drive this market.
3. The Americas are dominating the global market, with Europe following second.
4. The Asia-Pacific market will grow to $2.4 billion by 2023, reflecting a 13 percent CAGR.
5. Key market players include Boston Scientific, DePuy Synthes, Integra LifeSciences, Medtronic and Stryker.
More articles on devices:
NuVasive names BD exec to board: 5 things to know
Robots, R&D top focus for Smith & Nephew’s knee business in 2018: 6 key quotes from CEO Oliver Bohoun
Stryker, Medicrea & more: 4 device company mergers, acquisitions and agreements
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
